Millennium Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-70
Closed -$91K – 6776
2022
Q3
$91K Buy
+70
New +$129K ﹤0.01% 6000
2022
Q2
– Sell
-3
Closed -$13K – 7209
2022
Q1
$13K Buy
+3
New +$15.7K ﹤0.01% 6703

Other funds holding MTRI

Millennium Management's MTRI Position: Q4 2022 in Review

Millennium Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2022, closing a stake of 70 shares — an estimated $91K sold.

Millennium Management first reported a position in MTRI in Q1 2022 and held it in 2 quarters. The position peaked at $91K in Q3 2022. 3 funds tracked by Wall St. Rank hold MTRI as of Q4 2022.

  • Millennium Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 70 Mentari Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $91K.
  • Millennium Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Millennium Management's Mentari Therapeutics, Inc. Common Stock position peaked at $91K in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.